Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model

MLA

Seung-Hwa Lee, et al. “Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model.” Diagnostics, vol. 12, no. 2, Jan. 2022, p. 263. EBSCOhost, https://doi.org/10.3390/diagnostics12020263.

APA

Seung-Hwa Lee, Jungchan Park, Rae Woong Park, Seo Jeong Shin, Jinseob Kim, Ji Dong Sung, Dae Jung Kim, & Kwangmo Yang. (2022). Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model. Diagnostics, 12(2), 263. https://doi.org/10.3390/diagnostics12020263

Chicago

Seung-Hwa Lee, Jungchan Park, Rae Woong Park, Seo Jeong Shin, Jinseob Kim, Ji Dong Sung, Dae Jung Kim, and Kwangmo Yang. 2022. “Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model.” Diagnostics 12 (2): 263. doi:10.3390/diagnostics12020263.